SRC and neoplasm: Src activation is very common in colorectal and breast cancers and is frequently critical in tumor progression through multiple processes, including migration, invasion, anoikis resistance, disruption of cadherin-mediated cell-cell contacts, proliferation, and resistance to apoptosis [1,3].